AGP Executive Report
Last update: 8 hours agoBiotech Spotlight: Hansa Biopharma says its US Phase 3 ConfIdeS kidney-transplant results were accepted as a late-breaking oral abstract at the American Transplant Congress in Boston, with 12-month eGFR and safety data for highly sensitised patients. Nordic-India Momentum: Prime Minister Narendra Modi’s Oslo push with Norway, Sweden, Finland, Iceland and Denmark is being framed as a “green technology and innovation” strategic partnership—tying clean energy, digitalisation and research links to deeper trade and investment. Regulation Watch (Crypto): A new MiCA comparison piece argues MiCA, Dubai’s VARA and Singapore’s licensing regimes look similar on the surface, but differ in what they treat as the core crypto risk. Health & Society: Newcastle University disputes claims that Malaysia-trained doctors are shut out of UK postgraduate posts, while Europe’s STI figures hit record highs, with England highlighted as worst-hit. Local Angle (Finance): Liechtenstein’s PM tells finance leaders stability and continuity matter most as global change accelerates.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
![<![CDATA[EU CHMP Issues Positive Opinion for Perioperative Pembrolizumab/Enfortumab Vedotin in Cisplatin-Ineligible MIBC]]>](https://cdn.sanity.io/images/0vv8moc6/onclive/c32607911ff8c2b81ea841493078c23b4f97815c-1280x720.jpg)
.webp)
